Martínez García, M., Velasco, G., Pineda, E., Gil Gil, M., Alameda, F., Capellades, J., . . . Sepúlveda Sánchez, J. M. (2022). Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial.
Citación estilo ChicagoMartínez García, María, et al. Safety and Efficacy of Crizotinib in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial. 2022.
Cita MLAMartínez García, María, et al. Safety and Efficacy of Crizotinib in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial. 2022.
Precaución: Estas citas no son 100% exactas.